title: A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanib.
authors.forename: Damien
authors.initials: D
authors.lastname: Giacchero
authors.forename: Constanza
authors.initials: C
authors.lastname: Ramacciotti
authors.forename: Jean Philippe
authors.initials: JP
authors.lastname: Arnault
authors.forename: Maryse
authors.initials: M
authors.lastname: Brassard
authors.forename: Eric
authors.initials: E
authors.lastname: Baudin
authors.forename: Laurent
authors.initials: L
authors.lastname: Maksimovic
authors.forename: Christine
authors.initials: C
authors.lastname: Mateus
authors.forename: Gorana
authors.initials: G
authors.lastname: Tomasic
authors.forename: Janine
authors.initials: J
authors.lastname: Wechsler
authors.forename: Martin
authors.initials: M
authors.lastname: Schlumberger
authors.forename: Caroline
authors.initials: C
authors.lastname: Robert
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005499:Folliculitis / Q000139:chemically induced; D060831:Hand-Foot Syndrome / Q000209:etiology*; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D010787:Photosensitivity Disorders / Q000139:chemically induced; D010880:Piperidines / Q000009:adverse effects* / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use; D013964:Thyroid Neoplasms / Q000188:drug therapy*
chemical_list: D010880:Piperidines; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; C452423:vandetanib